Literature DB >> 27206212

Protective effects of dexmedetomidine on brain function of glioma patients undergoing craniotomy resection and its underlying mechanism.

Xiahong Luo1, Xia Zheng1, Hougang Huang2.   

Abstract

INTRODUCTION: To explore the protective effects of dexmedetomidine on brain of glioma patients undergoing craniotomy resection and its underlying mechanism.
METHODS: 60 cases of patients undergoing craniotomy resection of glioma were randomly divided into group C (n=30) and D (n=30). D group patients received dexmedetomidine vein pump injection at a dose of 1μg/kg 10min before anesthesia induction, with a maintain dose of 0.4μg/(kg/h). Group C patients received saline instead. Mean arterial pressure (MAP) and heart rate (heart rate, HR) were compared between the two groups of patients before anesthesia induction (T1), before tracheal intubation (T2), immediately after tracheal intubation (T3), 1min after tracheal intubation (T4), 3min after tracheal intubation (T5), 5min after tracheal intubation (T6). Expression levels of serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), superoxide dismutase (SOD), malondialdehyde (MDA), neuron-specific enolase of Enzyme (NSE) and S100β were compared between the two groups of patients before surgery, immediately post-surgery and 24h post-surgery.
RESULTS: No significant differences of MAP and HR between the two groups were found at T1, T2, T5 and T6 (P>0.05); The levels of MAP and HR in group C were significantly higher than those in group D at T3 and T4 (P<0.05). No significant differences of preoperative expression levels of serum TNF-α, IL-6, NSE, S100β, SOD and MDA were found between the two groups (P>0.05); Serum levels of TNF-α, IL-6, NSE, S100β and MDA were significantly reduced, whereas SOD was significantly increased in group D compared with those in group C at surgery time and 24h post-surgery (P<0.05).
CONCLUSION: Dexmedetomidine can significantly stabilize hemodynamics, reduce inflammation, and inhibit free radical generation, thus plays an important role on brain protection in patients undergoing craniotomy resection of glioma.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain protection; Dexmedetomidine; Glioma

Mesh:

Substances:

Year:  2016        PMID: 27206212     DOI: 10.1016/j.clineuro.2016.05.004

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  12 in total

1.  Propofol shows less negative effects on cognitive performances than dexmedetomidine in elderly intensive care unit patients.

Authors:  Yi Liu; Yuxia Ma; Yunfeng Liu; Wenhao Wang; Feifei Liu
Journal:  Neurol Sci       Date:  2021-01-15       Impact factor: 3.307

2.  Can Dexmedetomidine Be Effective in the Protection of Radiotherapy-Induced Brain Damage in the Rat?

Authors:  Seda Çınar; Levent Tümkaya; Tolga Mercantepe; Sinan Saral; Sema Rakıcı; Adnan Yılmaz; Atilla Topçu; Ahmet Şen; Sibel Karakaş
Journal:  Neurotox Res       Date:  2021-05-31       Impact factor: 3.911

3.  Dexmedetomidine reduces the neuronal apoptosis related to cardiopulmonary bypass by inhibiting activation of the JAK2-STAT3 pathway.

Authors:  Yanhua Chen; Xu Zhang; Bingdong Zhang; Guodong He; Lifang Zhou; Yubo Xie
Journal:  Drug Des Devel Ther       Date:  2017-09-26       Impact factor: 4.162

4.  Analysis of Dexmedetomidine on the Quality of Awakening During Neurosurgery.

Authors:  Jing Cao; Hui Li; Shengwen Song; Xuyan Zhou; Xu Shen
Journal:  Transl Neurosci       Date:  2019-07-12       Impact factor: 1.757

5.  Is It Time for an Expanded Role of Dexmedetomidine in Contemporary Anesthesia Practice? - A Clinician's Perspective.

Authors:  Christian Bohringer; Hong Liu
Journal:  Transl Perioper Pain Med       Date:  2018-04-12

6.  Exosomes of Antler Mesenchymal Stem Cells Improve Postoperative Cognitive Dysfunction in Cardiopulmonary Bypass Rats through Inhibiting the TLR2/TLR4 Signaling Pathway.

Authors:  Chun Yang; Shengnan Sun; Qi Zhang; Jia Guo; Tengfei Wu; Ying Liu; Min Yang; Yan Zhang; Yinghua Peng
Journal:  Stem Cells Int       Date:  2020-03-26       Impact factor: 5.443

7.  Neuroprotective effect of bispectral index-guided fast-track anesthesia using sevoflurane combined with dexmedetomidine for intracranial aneurysm embolization.

Authors:  Chao-Liang Tang; Juan Li; Zhe-Tao Zhang; Bo Zhao; Shu-Dong Wang; Hua-Ming Zhang; Si Shi; Yang Zhang; Zhong-Yuan Xia
Journal:  Neural Regen Res       Date:  2018-02       Impact factor: 5.135

8.  The Inflammatory Nature of Post-surgical Delirium Predicts Benefit of Agents With Anti-TNF Effects, Such as Dexmedetomidine.

Authors:  Ian A Clark; Bryce Vissel
Journal:  Front Neurosci       Date:  2018-04-19       Impact factor: 4.677

9.  Intraoperative Dexmedetomidine Versus Midazolam in Patients Undergoing Peripheral Surgery With Mild Traumatic Brain Injuries: A Retrospective Cohort Analysis.

Authors:  Jing Peng; Fujuan He; Chenguang Qin; Yuanyuan Que; Rui Fan; Bin Qin
Journal:  Dose Response       Date:  2020-04-07       Impact factor: 2.658

Review 10.  The Current Role of Dexmedetomidine as Neuroprotective Agent: An Updated Review.

Authors:  Zaara Liaquat; Xiaoying Xu; Prince Last Mudenda Zilundu; Rao Fu; Lihua Zhou
Journal:  Brain Sci       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.